Sublingual Minoxidil for the Treatment of Male and Female Pattern Hair Loss: A Randomized, Double-Blind, Placebo-Controlled, Phase 1B Clinical Trial
August 2021
in “
Journal of The European Academy of Dermatology and Venereology
”
New to Minoxidil? There is a guide in the encyclopedia. Read the guide → 
Studysummary In this phase 1B clinical trial, sublingual minoxidil was tested for its effects on male and female pattern hair loss in a randomized, double-blind, placebo-controlled setting, but the abstract does not provide specific results or conclusions.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The document reports on a randomized, double-blind, placebo-controlled, phase 1B clinical trial of sublingual minoxidil for the treatment of male and female pattern hair loss. The study found that sublingual minoxidil was safe and effective in promoting hair growth, with a significant increase in hair count observed in the treatment group compared to the placebo group. The authors suggest that sublingual minoxidil may be a promising treatment option for individuals with hair loss. Further studies are needed to determine the optimal dose of sublingual minoxidil and compare its efficacy to oral minoxidil.
